C7 - complement C7 Gene

Species: Macaca mulatta

Gene Type: protein coding
Gene ID: 696926

C7 Products (4)

mRNA Protein Name
XM_001085533.4 XP_001085533.4 complement component C7 isoform X2
XM_028849417.1 XP_028705250.1 complement component C7 isoform X1
XM_001085533.4 XP_001085533.4 complement component C7 isoform X2
XM_028849417.1 XP_028705250.1 complement component C7 isoform X1
Protein Preferred Names Protein Names

complement component C7

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9934 Abciximab Inhibitor 99.97% Unkown

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-N0216S6 Benzoic acid-13C7 Inhibitor / Phase 2

Pre-clinical Phase

Bioactive Molecules (99)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-150745A ODN 24987 sodium 99.08% Unkown
HY-W016103 1-Hydroxy-2-naphthoic acid 99.70% Unkown
HY-W088194 Boc-C7-COOH / Unkown
HY-W668775 Quin-C7 Antagonist 99.76% Unkown
HY-148671 (S,R,S)-AHPC-amido-C7-acid 98.71% Unkown
HY-150746A ODN 24991 sodium 99.64% Unkown
HY-161766 L687 Activator 99.49% Unkown
HY-W008821 1,7-Heptanediamine Inhibitor ≥98.0% Unkown
HY-149577 EBV lytic cycle inducer-1 Inducer 96.25% Unkown
HY-147128 PY109 Agonist 99.15% Unkown
HY-P10501A FRα-targeting peptide C7 TFA 99.76% Unkown
HY-133799 Pomalidomide-C7-COOH 95.35% Unkown
HY-136005 VH032-C7-COOH 99.92% Unkown
HY-150746 ODN 24991 Inhibitor 99.64% Unkown
HY-B0315S Vitamin B12-13C7 96.14% Unkown
HY-P3801 [Glp5,(Me)Phe8,Sar9] Substance P (5-11) Modulator 99.61% Unkown
HY-W012340S L-Homoarginine-13C7,15N4 hydrochloride 98.0% Unkown
HY-130640 (S,R,S)-AHPC-Me-C7 ester 95.49% Unkown
HY-131874 Thalidomide-O-C7-acid Inducer 98.55% Unkown
HY-131878 Pomalidomide-C7-NH2 hydrochloride 98.97% Unkown
HY-150745 ODN 24987 Inhibitor / Unkown
HY-163678 Pomalidomide-CO-C7-NH-CO-C3-COOH 98.55% Unkown
HY-16676 7-Epi-docetaxel Activator 98.76% Unkown
HY-176224 Anti-virulence factor-IN-2 Inhibitor 98.41% Unkown
HY-P10501 FRα-targeting peptide C7 / Unkown
HY-RS03384 CXCL10 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W011103 Diheptyl phthalate 98.64% Unkown
HY-W016087 Monoethyl pimelate / Unkown
HY-130949B Thalidomide-4-O-C7-NH2 hydrochloride 99.80% Unkown
HY-N6802 Tigloylgomisin H Inducer 98.37% Unkown
HY-130949 Thalidomide-4-O-C7-NH2 Inducer / Unkown
HY-128746S 2,6-Diaminoheptanedioic acid-13C7,15N2 / Unkown
HY-131622S 7-Aminoclonazepam-13C6 / Unkown
HY-131740 2'-Deoxytubercidin 5'-triphosphate / Unkown
HY-131740A 2'-Deoxytubercidin 5'-triphosphate sodium / Unkown
HY-136186 (S,R,S)-AHPC-C7-amine / Unkown
HY-136186B (S,R,S)-AHPC-C7-amine hydrochloride / Unkown
HY-149564 Thalidomide-5-O-C7-NH2 hydrochloride Inducer 98.13% Unkown
HY-149645 CB2 receptor antagonist 2 Antagonist / Unkown
HY-151274 SARS-CoV-2-IN-28 Inhibitor / Unkown
HY-151274A SARS-CoV-2-IN-28 disodium Inhibitor / Unkown
HY-151468 AIE-Cbz-LD-C7 / Unkown
HY-153541 AP-C7 Inhibitor / Unkown
HY-155263 Pomalidomide-5-C7-NH2 hydrochloride / Unkown
HY-155527 SARS-CoV-2 Mpro-IN-9 Inhibitor 99.31% Unkown
HY-155560 Pomalidomide-C7-NH2 / Unkown
HY-157437 AChE/BChE-IN-16 Inhibitor / Unkown
HY-157883 C7BzO Inhibitor / Unkown
HY-161379 CLZX-205 Inhibitor / Unkown
HY-161663 Phosphodiesterase-IN-2 Inhibitor / Unkown
HY-161933 1-Adamantane-amide-C7-NH2 / Unkown
HY-163758 COOH-C3-CONH-C7-COOH / Unkown
HY-163984 Antibacterial agent 240 Inhibitor / Unkown
HY-164799 FXR agonist 12 Agonist / Unkown
HY-167694 Antiproliferative agent-62 Activator / Unkown
HY-169006 Evo312 / Unkown
HY-173082 10-SLF Degrader / Unkown
HY-173580 7-Deaza-2'-deoxyadenosine-5'-O-triphosphate tetrasodium / Unkown
HY-174869 Pomalidomide-5-C7-NH2 / Unkown
HY-175241 T-01-C7-amide / Unkown
HY-176470 Thalidomide-N-C-piperidine-C7-Br / Unkown
HY-179720 TT-012-NH-C7-NHBoc / Unkown
HY-181189 Lenalidomide-C7-NH2 / Unkown
HY-181868 Lenalidomide-CO-C7-NH2 / Unkown
HY-181882 MV78-OH-C7-COOH / Unkown
HY-186154 Thalidomide-amine-C7-acid / Unkown
HY-CE01248 C7:0-CoA / Unkown
HY-N10344 Glucoarabin Activator / Unkown
HY-N6779S Patulin-13C7 / Unkown
HY-N7777 7-Xylosyl-10-Deacetyltaxol C / Unkown
HY-P3972 H-ILE-ARG-VAL-VAL-MET-OH / Unkown
HY-RS01753 C7 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01754 C7orf50 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS05971 H3C7 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS12598 SDR9C7 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W142432S Perfluoroundecanoic acid-13C7 / Unkown
HY-W334800S (2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2 / Unkown
HY-W334800S2 (2S,6S)-2,6-Diaminoheptanedioic acid-13C7 / Unkown
HY-W753671 2,6-Diaminoheptanedioic acid-13C7 / Unkown
HY-W767186 D-Mannoheptulose-13C7 / Unkown
HY-W940797 Thalidomide-O-amido-C7-NH2 / Unkown
HY-Y1027S 2-Chlorobenzoic Acid-13C7 / Unkown
HY-100807S1 Quinolinic acid-13C7 / Unkown
HY-103447S2 Zearalenone-13C7 Activator / Unkown
HY-118051 LY 186826 / Unkown
HY-136186A (S,R,S)-AHPC-C7-amine dihydrochloride / Unkown
HY-14283S Luliconazole-13C7 / Unkown
HY-159204 3'-Amino-Modifier C7 CPG 1000 / Unkown
HY-162862 JAK-IN-38 / Unkown
HY-180442 7-BioQ / Unkown
HY-181356 (S,R,S,R)-AHPC-Me-CO-C7-N3 / Unkown
HY-B0495S8 Lamotrigine-13C7,15N / Unkown
HY-RS16518 Cxcl10 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17240 C7 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20317 Oxr1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23694 C7 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W278073 RNA splicing modulator 6 Modulator / Unkown
HY-W800743 Heptyl 6-bromohexanoate / Unkown
HY-W939883 Thalidomide-4-O-C7-Br / Unkown
Bioactive MoleculesInhibitory Antibodies (3)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P991608 CTM01 Inhibitor / Unkown
HY-P991573 Anti-EGFR Antibody (D2C7) Inhibitor / Unkown
HY-P991857 Anti-Human/Mouse/Bovine ADAM10 Antibody (8C7) / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens C7 NCBI NCBI:730